Please login to the form below
ViroPharma
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of ViroPharma's 2013 immunology sales performance.
Nabriva Therapeutics appoints chief medical officer
Her career has seen her hold positions at Shire, ViroPharma, Pfizer, GlaxoSmithKline and Merck &Co.
Merck says drug for CMV in transplant patients hits targets
phase III testing that it acquired along with ViroPharma in 2013.
FDA grants fast track designation to Shire’s Cinryze
At the end of 2013, Shire signed a deal with US company Viropharma for around $4.2bn which gave the company rights to Cinryze.
Pharma deals in August 2015
indication]. Interestingly, the right to make the Meritage acquisition came via the purchase of ViroPharma.
Medius Deal Watch table for February 2015
Turkey. † US. †† Financial details source - Viropharma's 2013 Consolidated Financial Statement. .
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
-
SENIOR MEDICAL WRITER
-
Salary TBC
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Senior Account Director - Med Comms Agency
-
Salary TBC
- Sinovac’s COVID-19 vaccine appears safe in older adults
- STEM Healthcare founder Rob Wood secures a 25% stake in performance-io
- Pfizer/BioNTech and Moderna increase COVID-19 vaccine supplies to the EU
- AZ/Oxford University vaccine shows 82.4% efficacy with extended dosing schedule
- AZ sells stake in Moderna for around $1.2bn
- Pfizer/BioNTech vaccine is 94% effective after second dose, major real-world study finds
- Syneos Health Communications announces senior hires to Europe-based team
- First shipments of AZ/Oxford COVID-19 vaccine sent through COVAX
- Merck & Co to help produce J&J’s COVID-19 vaccine in the US
- AbbVie buys exclusive right to acquire Mitokinin’s Parkinson’s asset
- Andi Goes – the children’s book that helps detect early signs of dyslexia
- UK study finds Pfizer/BioNTech, AZ/Oxford vaccines reduce severe COVID-19 in older people
PMHub
Research Partnership
We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...
Latest intelligence
- Good design saves lives
- Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
- Why you must understand the pricing of patient recruitment companies
- Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
- A cultural shift in clinical research
- Research organisations across the board are experimenting with new technologies...
Quick links
Infographics
